Gilead Sciences INC GILEAD SCIENCES ORD SHS
Gilead Sciences INC GILEAD SCIENC.../ US3755581036 /
0QYQ
|
24/05/2024 18:04:40
|
Chg.
-
|
Volume |
Bid18:30:00 |
Demandez à18:30:00 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
66.42USD
|
-
|
6,526
Chiffrre d'affaires: 96,741.02 |
-Bid taille: - |
-Ask la taille: - |
110.17 Mrd.USD |
3.39% |
19.47 |
Description de l'entreprise
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Conseil d'administration & Conseil de surveillance
| PDG |
| Daniel O’Day |
| Conseil d'administration |
| Andrew Dickinson, Jyoti Mehra, Stacey Ma, Flavius Martin, Johanna Mercier, Cindy Perettie, Deborah H. Telman, Merdad Parsey |
| Conseil de surveillance |
| Daniel O’Day, Jacqueline K. Barton, Jeffrey A. Bluestone, Sandra J. Horning, Kelly A. Kramer, Harish Manwani, Anthony Welters, Ted W. Love, Javier J. Rodriguez |
Données de l'entreprise
| Nom: |
Gilead Sciences Inc. |
| Adresse: |
333 Lakeside Drive,Foster City, California 94404, USA |
| Téléphone: |
+1-650-574-3000 |
| Fax: |
+1-650-578-9264 |
| Courriel: |
corporate_developmen...ad.com
corporate_development@gilead.com
|
| Internet: |
www.gilead.com |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
99.89% |
| IPO date: |
22/01/1992 |
Calendrier de l'entreprise
|
CW 50 | 13/12/2024
Record Date
|
|
CW 50 | 13/12/2024
Ex-Dividend
|
|
CW 53 | 30/12/2024
Dividend Payment
|
Principaux actionnaires
| Autres |
|
55.91% |
| BlackRock Inc. |
|
9.86% |
| Vanguard Group |
|
8.98% |
| Capital World Investors |
|
6.69% |
| CAPITAL RESEARCH GLOBAL INVESTOR |
|
4.79% |
| State Street Corporation |
|
4.78% |
| Dodge & Cox |
|
2.67% |
| GEODE CAPITAL MANAGEMENT LLC |
|
2.03% |
| Wellington Management Group |
|
1.50% |
| Autres |
|
2.80% |
